Blue Elephant Inc

Form 483 issued May 16, 2025 · Southlake, Texas

Inspection
May 9 – May 16, 2025
Observations
9
Pages
8
FEI number
3031025053

In short: On May 16, 2025, FDA issued a Form 483 with 9 observations to Blue Elephant Inc in Southlake, Texas (FEI 3031025053) after an inspection that ran May 9 – May 16, 2025. The investigator was Elizabeth A. Krolczyk. Most observations concern design controls and records & documents; the most-cited regulation is 21 CFR 820.30 (design controls).

At a glance

6 of 9 observations on this 483 concern design controls.

Design controls6
Records & documents1
Production & process controls1
Management controls1

Most cited: 21 CFR 820 (2×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Observation 1: scanned text, readable in the full document.

  2. 02

    A device master record…

  3. 03

    Design plans that describe or reference the design and development activities and define responsibility for implementation…

  4. 04

    Design input requirements were…

5 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Blue Elephant Inc?

FDA listed 9 observations on this Form 483, mostly about design controls, records & documents and production & process controls. The most-cited regulation is 21 CFR 820.30 (design controls). The opening words of each observation are shown on this page.

Who inspected Blue Elephant Inc?

Elizabeth A. Krolczyk is named on this Form 483, for the inspection of May 9 – May 16, 2025. Each investigator has a profile showing what they cite most.

When was Blue Elephant Inc inspected by FDA?

The inspection ran May 9 – May 16, 2025, and the Form 483 is dated May 16, 2025.

How do I get the full Form 483 for Blue Elephant Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free